Peter Brandt Net Worth - Insider Trades and Bio as of Jun 9, 2026

INABIN8BIO, INC.SEC CIK: 0001434099

Estimated Net Worth

$3.76 Million

Last Updated: May 19, 2026 11:37 PM EST

Transaction Summary

Total Transactions51

Buy-Sell Ratio∞

Buy Transactions8

Sell Transactions0

Transaction Volume

Total Volume$1.31M

Net Volume$1.31M

Buy Volume$1.31M

Sell Volume$0.00

Trade Analysis

AVG Trade Size-$97.99K

Largest Trade$259.14K

Most Active MonthJun

Most Active Year2011

Trading Sentiment

OverallBullish

Recent TradeNeutral

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Peter C. Brandt has an estimated net worth of $3.76 Million. This is based on reported shares across multiple companies, which include IN8BIO, INC., REXAHN PHARMACEUTICALS, INC., AUXILIUM PHARMACEUTICALS INC, EPOCRATES INC, and NOVEN PHARMACEUTICALS INC.

2011 was Peter C. Brandt's most active year for acquiring shares with 33 total transactions. Peter C. Brandt's most active month to acquire stocks was the month of August. 2015 was Peter C. Brandt's most active year for disposing of shares, totalling 7 transactions. Peter C. Brandt's most active month to dispose stocks was the month of December. 2011 saw Peter C. Brandt paying a total of $672,525.15 for 412,035 shares, this is the most they've acquired in one year. In 2009 Peter C. Brandt cashed out on 857,712 shares for a total of $4,867,500.00, their largest year based on trade value.

Holdings & Transactions

INABin8bio, inc.

Updated: May 12, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	22.00K	—	—	May 12, 2026	22.00K	Grant	—	May 09	View
From 4	3.19	72.46K	$1.38	$100.00K	Dec 23, 2025	98.69K	Grant	—	Dec 22	View
From 4	—	63.15K	—	—	May 12, 2025	63.15K	Grant	—	May 08	View
From 4	—	—	$0.18	$30.23K	May 07, 2025	786.83K	Options	—	Apr 27 - 30	View
From 4	—	49.49K	—	—	Dec 23, 2024	49.49K	Grant	—	Dec 19	View
From 4	1.46	506.33K	—	—	Oct 08, 2024	958.03K	Acquisition	—	Oct 04	View
From 4	—	33.65K	—	—	Jun 14, 2024	33.65K	Grant	—	Jun 12	View
From 4	1.35	245.90K	—	—	Dec 15, 2023	533.66K	Grant	—	Dec 13	View
From 4	—	85.00K	—	—	Jun 16, 2023	85.00K	Grant	—	Jun 15	View
From 4/A	—	13.50K	—	—	Sep 23, 2022	13.50K	Grant	—	Jun 01	View
From 4	1.36	105.26K	$1.90	$200.00K	Aug 18, 2022	287.76K	Purchase	—	Aug 16	View
From 4	—	10.50K	—	—	Jun 14, 2022	10.50K	Grant	—	Jun 01	View
From 4	—	10.50K	—	—	Aug 02, 2021	10.50K	Grant	—	Jul 29	View
From 3	—	—	—	—	Jul 29, 2021	182.50K	—	—	—	View

OCUPrexahn pharmaceuticals, inc.

Updated: Jun 07, 2019VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	3.54K	—	—	Jun 07, 2019	3.54K	Grant	—	Jun 06	View
From 4	—	39.74K	—	—	Jun 29, 2018	39.74K	Grant	—	Jun 28	View
From 4	—	110.00K	—	—	Apr 12, 2017	110.00K	Grant	—	Apr 11	View
From 4	—	225.00K	—	—	Jun 10, 2016	225.00K	Grant	—	Jun 09	View
From 4	—	90.00K	—	—	Sep 18, 2015	90.00K	Grant	—	Sep 16	View
From 4	—	60.00K	—	—	Jun 11, 2014	60.00K	Grant	—	Jun 09	View
From 4	—	60.00K	—	—	Jun 13, 2013	270.00K	Grant	—	Jun 11	View
From 4	—	20.00K	—	—	Jun 20, 2012	210.00K	Grant	—	Jun 18	View
From 4	5.00	125.00K	$1.17	$146.86K	Sep 12, 2011	190.00K	Purchase	—	Sep 08 - 09	View
From 4	—	25.00K	$0.96	$24.12K	Sep 08, 2011	65.00K	Purchase	—	Sep 06 - 07	View
From 4	—	20.00K	—	—	Jun 08, 2011	40.00K	Grant	—	Jun 06	View
From 4	—	20.00K	—	—	Oct 25, 2010	20.00K	Grant	—	Sep 17	View
From 3	—	—	—	—	Oct 06, 2010	—	—	—	—	View

auxilium pharmaceuticals inc

Updated: Jan 30, 2015

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	70.00K	$36.53	-$1.83M	Jan 30, 2015	—	Disposition	—	Jan 29	View
From 4	0.50	10.00K	—	—	May 22, 2014	30.00K	Grant	—	May 21	View
From 4	0.67	10.00K	—	—	May 03, 2013	25.00K	Grant	—	May 01	View
From 4	1.00	10.00K	—	—	Jun 22, 2012	20.00K	Grant	—	Jun 21	View
From 4	—	10.00K	$20.10	$201.00K	Mar 01, 2012	10.00K	Purchase	—	Feb 28	View
From 4	—	15.00K	—	—	Jun 20, 2011	15.00K	Grant	—	Jun 16	View
From 4	—	15.00K	—	—	Dec 20, 2010	15.00K	Grant	—	Dec 16	View
From 3	—	—	—	—	Dec 20, 2010	—	—	—	—	View

epocrates inc

Updated: Mar 13, 2013

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	181.96K	—	—	Mar 13, 2013	—	Disposition	—	Mar 12	View
From 4	—	11.79K	—	—	Aug 14, 2012	11.79K	Grant	—	Aug 13	View
From 4	6.82	170.59K	—	—	Dec 09, 2011	195.60K	Grant	—	Dec 07	View
From 4	1.40	14.57K	$9.78	$142.43K	Sep 09, 2011	25.00K	Purchase	—	Sep 07	View
From 4	—	10.43K	$9.58	$99.97K	Sep 08, 2011	10.43K	Purchase	—	Sep 06	View
From 4	—	11.79K	$21.98	$259.14K	May 10, 2011	11.79K	Grant	—	May 06	View
From 4	—	19.65K	—	—	Feb 02, 2011	19.65K	Grant	—	Feb 01	View
From 3	—	—	—	—	Feb 01, 2011	—	—	—	—	View

noven pharmaceuticals inc

President and CEO Director

Updated: Aug 27, 2009

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	746.04K	$16.50	-$3.02M	Aug 27, 2009	—	Disposition	—	Aug 27	View
From 4	-0.38	111.67K	$16.50	-$1.84M	Aug 21, 2009	183.33K	Disposition	—	Aug 20	View
From 4	—	62.71K	—	—	Feb 06, 2009	62.71K	Grant	—	Feb 04	View
From 4	—	188.47K	—	—	Nov 24, 2008	188.47K	Grant	—	Nov 21	View
From 4	0.07	20.00K	$12.39	$247.78K	Sep 02, 2008	295.00K	Purchase	—	Aug 29	View
From 4	0.10	25.00K	$9.79	$244.87K	May 15, 2008	275.00K	Purchase	—	May 13 - 14	View
From 4	—	561.53K	—	—	May 01, 2008	561.53K	Grant	—	Apr 29	View
From 3	—	—	—	—	May 01, 2008	—	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions